Delivery Order SPE2DB22D2007-SPE2DB25FJ1AH

Award Date 4/28/25
Potential Completion Date 5/19/25
Potential Value $7.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,400 mg-23,400 11.7 ml vials of the drug Rituxan Hycela, with a ceiling value of $74,092.00 and a completion date of June 7, 2023. The contract was awarded on May 16, 2023 and is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Rituxan Hycela, a specialty medication, with a ceiling value of $3,718.02. This is a firm-fixed-price delivery order contract with a completion date of February 26, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $36,664.56, is for the delivery of Rituxan Hycela, a specialty medication, and does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which runs through December 2025....
This federal contract award (SPE2DB20D3103|SPE2DB22FM4X7) was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 1,400 mg-23,400 11.7 ml units of the drug Rituxan Hycela. The contract has a ceiling value of $11,738.44 and was awarded on a firm fixed-price basis, with a completion date of February 23, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of various pharmaceutical and medical products. The $140,578.74 contract has an ultimate completion date of April 29, 2025. AmerisourceBergen, a for-profit organization based in Conshohocken, Pennsylvania, will supply a range of medications and medical supplies, including diabetes treatments, neurological drugs, pain...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation. The contract, valued at $17,173.08, is for the delivery of pharmaceutical and medical products to support military treatment programs and facilities worldwide. AmerisourceBergen, a major pharmaceutical distributor, is delivering a variety of critical care materials such as syringes, vials, and test kits, as well as a diverse range of medications. This...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,052.52, is for the delivery of various pharmaceutical products and medical supplies to support military healthcare programs. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 22, 2025. Amerisourcebergen Drug Corp, headquartered in...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $554,521.18, is for the delivery of a variety of pharmaceutical products and medical supplies to support military healthcare programs. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999.00, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,536.58, is for the delivery of a range of pharmaceutical products and medical supplies to support military healthcare programs. The contract is a firm fixed-price delivery order, with an ultimate completion date of March 20, 2025. Amerisourcebergen Drug Corp is a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $20,513.52, is for the delivery of pharmaceutical and medical products to support military healthcare programs. It is a firm fixed-price contract with an ultimate completion date of April 29, 2025. The contract is not set aside for any specific business type....
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FJ1AH
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,436.04, is for the delivery of Rituxan Hycela, a medication used for the treatment of certain types of cancer and autoimmune disorders. The contract is a firm-fixed-price, non-set-aside delivery order with a performance period ending on May 19, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a for-profit organization that serves as a critical supplier of medical and pharmaceutical products to federal agencies, including the DLA, U.S. Coast Guard, and Defense Health Agency. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026.

Generated 7/28/25, 11:17 AM